Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study

Detalles Bibliográficos
Autores principales: Thein, Kyaw Z., Fu, Siqing, Janku, Filip, Tsimberidou, Apostolia M., Piha-Paul, Sarina A., Karp, Daniel D., Shah, Jatin, Milton, Denái R., Gong, Jing, Sulovic, Selma, McQuinn, Lacey, Stephen, Bettzy A., Colen, Rivka R., Carter, Brett W., Meric-Bernstam, Funda, Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138422/
https://www.ncbi.nlm.nih.gov/pubmed/35663832
http://dx.doi.org/10.36401/JIPO-21-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138422/
https://www.ncbi.nlm.nih.gov/pubmed/35663832
http://dx.doi.org/10.36401/JIPO-21-20

Ejemplares similares